Alkermes plc. (ALKS) stock

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value

$47.89+1.42 (+3.06%)

Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –

Alkermes statistics

102 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 24, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $8.03B; $282.97M
Enterprise Value: $8.88B; $154.96M
PE Ratio: 126.03; 25.08
PS Ratio: 4.82; 3.71
PB Ratio: 4.44; 2.17
P/FCF Ratio: 36.25; 19.12
P/OCF Ratio: 31.99; 13.11

Enterprise valuationIndustry

EV / Sales: 5.33; 2.65
EV / EBITDA: 49.64; 16.59
EV / EBIT: 75.74; 19.03
EV / FCF: 40.07; 22.15

Share statisticsIndustry

Shares Outstanding: 168M; 58M
Shares Change (YoY): 1.12%; 10.9%
Shares Change (QoQ): 0.65%; 0.51%
Float: 165M; 49M
Shares Held by Insiders: 1.56%; 11.6%
Shares Held by Institutions: 106.1%; 56.4%

Short sellingIndustry

Short Interest: 20M; –
Short Interest Change: 3.15%; -0.76%
Short % of Float: 11.9%; 9.06%
Short % of Shares Outstanding: 11.7%; 6.38%
Days to Cover: 11.25; 5.16

Stock price statisticsIndustry

52-Week High: $55.67; –
52-Week Low: $27.00; –
20-Day Moving Average: $44.59; –
50-Day Moving Average: $43.68; –
200-Day Moving Average: $41.00; –
Average True Range (14): $1.64; –
Price Change (1 Week): 4.36%; -0.50%
Price Change (1 Month): 20.5%; -0.33%
Price Change (3 Months): -3.15%; -17.2%
Price Change (6 Months): 23.1%; -20.1%
Price Change (YTD): 71.2%; -20.1%
Price Change (1 Year): 46.7%; -19.3%
Price Change (3 Years): 101.2%; -23.4%
Price Change (5 Years): 99.7%; -76.4%
Price Change (10 Years): -18.2%; -62.4%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 2M; –
Average Volume (90 Days): 2M; –
Relative Volume: 0.56; 0.73
Relative Strength Index (14): 67.6; 47.6
Volatility (1 Year): 40.5%; 80.2%
Beta (5 Years): 0.42; 1.07

MarginsIndustry

Gross Margin: 84.6%; 53.1%
Operating Margin: 7.03%; -37.1%
Pretax Margin: 5.84%; -12.1%
Profit Margin: 3.97%; -32.3%
EBITDA Margin: 10.7%; -25.0%
FCF Margin: 13.3%; -9.55%

Returns on capitalIndustry

Return on Equity (ROE): 3.85%; -51.3%
Return on Assets (ROA): 1.99%; -40.3%
Return on Invested Capital (ROIC): 4.88%; -34.0%
Return on Capital Employed (ROCE): 3.14%; -37.7%

Financial positionIndustry

Current Ratio: 2.30; 3.30
Quick Ratio: 1.68; 2.37
Debt / Equity: 0.83; 0.49
Debt / EBITDA: 8.40; 3.15
Debt / FCF: 6.78; 4.62
Net Debt / EBITDA: 4.73; 1.97
Interest Coverage: 1.98; -6.27

GrowthIndustry

Revenue Growth (YoY): 10.8%; 7.01%
Net Income Growth (YoY): -81.0%; -24.7%
EPS Growth (YoY): -81.7%; -12.8%
FCF Growth (YoY): -53.8%; 6.85%
Revenue Growth (3Y CAGR): 9.90%; 2.25%
Revenue Growth (5Y CAGR): 7.28%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.50; 0.40
Inventory Turnover: 1.05; 2.68
Revenue Per Employee: $813.49K; $426.63K
Profits Per Employee: $32.26K; -$680.86K
Employee Count: 2,050; 75
WACC: 6.74%; 10.1%

Income statement (TTM)Industry

Revenue: $1.67B; $66.56M
Gross Profit: $1.41B; $111.43M
Operating Income: $117.26M; -$20.20M
Pretax Income: $97.32M; -$13.50M
Net Income: $66.12M; -$21.57M
EBITDA: $178.89M; -$16.36M
EPS (Diluted): $0.38; -$0.77

Balance sheetIndustry

Cash & Short-Term Investments: $656.58M; $65.30M
Total Debt: $1.50B; $118.49M
Net Cash (Debt): -$846.53M; $16.31M
Net Cash Per Share: -$5.05; $0.70
Equity (Book Value): $1.81B; $53.12M
Book Value Per Share: $10.78; $1.49
Tangible Book Value: -$547.18M; $26.11M
Working Capital: $860.82M; $77.59M

Cash flow (TTM)Industry

Operating Cash Flow: $251.18M; -$12.07M
Capital Expenditures: -$29.53M; -$939.00K
Free Cash Flow: $221.65M; -$18.37M
FCF Per Share: $1.32; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 0.82%; -19.8%
FCF Yield: 2.76%; -8.81%

Taxes and interestIndustry

Interest Expense: $59.09M; $2.98M
Income Tax: $31.20M; $79.50K
Effective Tax Rate: 32.1%; 20.7%

Scores and fair valueIndustry

Graham Number: $9.60; $19.42
Graham Upside: -80.0%; -45.8%
Altman Z-Score: 2.31; 0.28
Piotroski F-Score: 7; 4
Beneish M-Score: -3.29; -2.62

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	ALKS	S&P 500	Difference	ALKS per year	S&P 500 per year
1 month	+17.9%	-2.4%	+20.3 pts
3 months	-2.7%	-1.2%	−1.5 pts
Year to date	+71.2%	+12.3%	+58.9 pts
1 year	+41.6%	+12.4%	+29.2 pts
3 years	+101.2%	+78.8%	+22.4 pts	+26.2%	+21.4%
5 years	+95.3%	+75.2%	+20.1 pts	+14.3%	+11.9%
10 years	-18.2%	+311.1%	−329.3 pts	-2.0%	+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

20M ALKS shares were sold short on Oct 30, 2026, up 3.1% from the previous report, or 11.90% of the shares available to trade. At recent volumes it would take 11.3 days to buy them back. Over the last 20 sessions, 60.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	19,647,994	+3.1%	1,746,478	11.3
Oct 15, 2026	19,048,577	+6.9%	2,088,388	9.1
Sep 30, 2026	17,821,179	+17.6%	2,839,345	6.3
Sep 15, 2026	15,156,775	+3.0%	1,416,869	10.7
Aug 31, 2026	14,717,404	-0.3%	1,248,178	11.8
Aug 14, 2026	14,761,342	+2.5%	1,448,036	10.2
Jul 31, 2026	14,406,911	-4.1%	1,866,095	7.7
Jul 15, 2026	15,017,743	-14.0%	1,648,870	9.1
Jun 30, 2026	17,464,944	-2.8%	3,631,213	4.8
Jun 15, 2026	17,962,751	+3.5%	1,899,270	9.5
May 29, 2026	17,355,226	-5.0%	2,054,158	8.4
May 15, 2026	18,277,684	-7.5%	2,420,484	7.5